Profile cover photo
Profile photo
MD Anderson Cancer Center
Making Cancer History®
Making Cancer History®

MD Anderson Cancer Center's posts

Post is pinned.Post has attachment
The University of Texas MD Anderson Cancer Center has been ranked the nation’s top hospital for cancer care, according to U.S. News and World Report's annual “Best Hospitals” survey. MD Anderson has ranked as one of the nation’s top two hospitals for cancer care every year since the survey’s inception in 1990.

“It’s an honor to once again be recognized as the nation’s top hospital for cancer care, which we have earned through our unrelenting passion to serve patients and fulfill our mission to end cancer,” said MD Anderson President Ronald A. DePinho, M.D. “We thank our patients and their loved ones who entrust us with their care and salute the 21,000 cancer fighters and 1,000 volunteers who make up our distinctive culture of exceptional care and compassionate caring.”

Learn more: #cancer #cancertreatment   #cancercare   #usnews   #hospital   #hospitals   #endcancer  

Post has attachment
Congratulations to our Dr. Jim Allison, who has been named one of +TIME’s 100 Most Influential People of 2017.

Dr. Allison’s immunotherapy research launched a completely new way to treat cancer by training the immune system to attack cancer. This breakthrough, called immune checkpoint blockade, has helped extend patients’ lives and transform cancer research.

“We’re in the early days of successful cancer immunotherapy. Our next step is to extend these treatments to benefit more patients and our platform is intensely focused on making that a reality,” says Allison, who is executive director of MD Anderson’s Immunotherapy Platform, which is part of our Moon Shots Program.
“The next challenge is to understand who benefits from treatment, who doesn’t, and develop rational combination therapies to help those who don’t,” Allison says. “There are many possible combinations – with other immunotherapies, targeted therapies, chemotherapies, radiation – and basic science will be important to help us more efficiently sort out these options.”

Read more about Dr. Allison’s immunotherapy research:

#Time100 #CancerMoonshot #immunotherapy #cancertreatment #clinicaltrials #mdanderson #cancerresearch #endcancer


Post has attachment
After Georgia Dominick was diagnosed with lung cancer and told she had only a year live, she came to The University of Texas MD Anderson Cancer Center for a second opinion. Here, she learned about an immunotherapy clinical trial for her exact type of lung cancer.

Within three months of entering the clinical trial, she was considered “virtually cancer-free.”

Now, two years since her diagnosis, she’s still living without any evidence of lung cancer.

“MD Anderson and the clinical trial saved my life,” Georgia says. “And for that, I am thankful every day. But it is also very rewarding to be involved in something so big and cutting-edge.”

#cancer #cancertreatment #clinicaltrial #hospital #cancersucks #lungcancer #mdanderson #endcancer

Post has attachment
What are Phase I clinical trials, and what role do they play in the discovery of new cancer treatments and cancer prevention? Dr. David Hong, deputy chair of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center, explains the benefits and drawbacks of Phase I clinical trials and which cancer patients should consider them.

#cancer #cancertreatment #clinicaltrials #cancersucks #hospital #mdanderson #endcancer

Post has attachment
Treesa Gold’s doctor urged her to seek specialized care after he removed a 13-centimeter adrenal gland tumor, along with her left kidney.

“My doctor said, ‘I will only see one case of this in your lifetime, and you want to go somewhere where they see many of these cases,’” she recalls.

So Treesa traveled to The University of Houston MD Anderson Cancer Center in Houston from New Orleans. Because adrenocortical carcinoma has a very high recurrence rate, Treesa started taking an oral chemotherapy drug called Mitotane to suppress her adrenal gland hormone production.

Eleven years later, she’s still cancer-free and giving back by supporting other adrenal gland tumor patients.

#cancer #cancertreatment #cancersucks #mdanderson #hospital #houston #endcancer

Post has attachment
The University of Texas MD Anderson Cancer Center’s Orthopedic Oncology program is pushing the boundaries of cancer treatment and giving patients more options.

Luke Adkins came to MD Anderson after doctors in Lubbock, Texas, told him that amputation was his only option after he was diagnosed with osteosarcoma, a type of sarcoma. Here, Dr. Valerae Lewis gave Luke another option: a surgery to replace his entire left knew and part of his femur with an internal prosthesis.

“I was in Houston for about a month after the surgery, and when I left, I walked out of hospital,” Luke says.

Jillian Williams also feared losing her leg after she was diagnosed with Ewing’s sarcoma. But she was able to undergo a rotationplasty, in which the lower portion of the leg is rotated and reattached backwards so that the ankle can function as a type of knee joint.

And Jacob Ballard, a teenage Ewing’s sarcoma survivor, is active today after undergoing a hemipelvectomy, a procedure in which one entire side of the pelvic bone is removed.

Learn more about how our Orthopedic Oncology program helped these patients.
#cancer #cancertreatment #osteosarcoma #mdanderson #hospital #treatment #orthopedic #oncology #sarcoma #houston #endcancer

Post has attachment
Karlee Steele refers to her third melanoma diagnosis as her “big cancer.” With a stage III melanoma diagnosis, she refused to take any chances and turned to The University of Texas MD Anderson Cancer Center for help. Here, Karlee underwent surgery then enrolled in an immunotherapy clinical trial.

“Over time, the immunotherapy worked, gradually shrinking and ultimately eliminating the melanoma,” Karlee says. “Today, I’m cancer-free, no longer in treatment and grateful to have my life back.”

Karlee now shares her story to encourage other cancer patients to consider clinical trials for their cancer treatment.

#cancer #cancersucks #cancertreatment #melanoma #immunotherapy #clinicaltrial #mdanderson #hospital #melsm #houston #endcancer

Post has attachment
Nadine Beech was a healthy, non-smoking 27-year-old when her first lung cancer symptom appeared.

“I started spitting up blood after a water skiing accident, and my doctor thought I had a bruised lung,” Nadine says.

Eventually, another doctor discovered an 8-centimeter tumor on the lower lobe of her left lung. Nadine had a lobectomy, but two years later, three small tumors formed in her right lung.

Heeding the advice of a friend, the Kansas City, Missouri, resident came to The University of Texas MD Anderson Cancer Center in Houston for lung cancer treatment. That was in 1999. Nadine’s lung cancer journey lasted another 17 years, but thanks to a recent surgery, she’s finally in remission. Read her entire story here:

#cancer #lcsm #lungcancer #cancersucks #cancertreatment #mdanderson #hospital #houston #surgery #endcancer

Post has attachment
U.S. Army veteran Tate Landin returned from the war in Afghanistan to face a new battle at home: brain cancer. Tate experienced his first brain tumor symptoms while he was deployed, but he ignored them so he could stay with his troop. When Tate returned to Texas nearly two years later, a biopsy revealed he had stage IV glioblastoma, an aggressive brain tumor. Tate came to The University of Texas MD Anderson Cancer Center for brain cancer surgery and treatment, and now he’s impressing doctors with his recovery. Read his full story:

#braincancer #btsm #cancersucks #cancer #mdanderson #surgery #physicaltherapy #hospital #houston #endcancer


Post has attachment
A stem cell transplant, or a bone marrow transplant, is often a lifesaving option for patients diagnosed with blood cancers, such as leukemia and lymphoma. But not all patients undergo the same type of stem cell transplant. In this Q&A, Dr. Borje S. Andersson. at The University of Texas MD Anderson Cancer Center explains the differences between an allogeneic stem cell transplant, an autogolous stem cell transplant and a hematopoietic stem cell transplant. #cancer #cancertreatment #stemcells #transplant #bonemarrow #cancersucks #hospital #mdanderson #houston #leusm #lymsm #endcancer

Wait while more posts are being loaded